Ligand Pharmaceuticals LGND Deferred Taxes
Deferred Taxes at other companies
Other financials
Where this comes from
Reported directly by Ligand Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:DeferredIncomeTaxLiabilitiesNet.
The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ligand Pharmaceuticals's deferred taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ligand Pharmaceuticals's deferred taxes?
- Ligand Pharmaceuticals (LGND) reported deferred taxes of $22.61M in Q1 2026.
- How has Ligand Pharmaceuticals's deferred taxes changed year-over-year?
- Ligand Pharmaceuticals's deferred taxes decreased by 23.0% year-over-year, from $29.38M to $22.61M.
- What is the long-term trend for Ligand Pharmaceuticals's deferred taxes?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's deferred taxes has grown at a -11.0% compound annual growth rate (CAGR), from $64.6M to $36.02M.
- What does deferred taxes mean?
- This represents the net amount of income taxes that will be payable in future periods due to temporary differences between the carrying amount of assets and liabilities for financial reporting and their tax bases. It reflects the long-term tax impact of accounting choices and depreciation schedules. Investors use this to understand future tax obligations and the impact of tax timing on cash flow.